BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 38304520)

  • 1. Evaluation of salivary MMP-9 in oral squamous cell carcinoma and oral leukoplakia using ELISA.
    Pazhani J; Chanthu K; Jayaraman S; Varun BR
    J Oral Maxillofac Pathol; 2023; 27(4):649-654. PubMed ID: 38304520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Verification of Saliva Matrix Metalloproteinase-1 as a Strong Diagnostic Marker of Oral Cavity Cancer.
    Chang YT; Chu LJ; Liu YC; Chen CJ; Wu SF; Chen CH; Chang IY; Wang JS; Wu TY; Dash S; Chiang WF; Chiu SF; Gou SB; Chien CY; Chang KP; Yu JS
    Cancers (Basel); 2020 Aug; 12(8):. PubMed ID: 32823758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salivary Tumour Necrosis Factor-α as a Biomarker in Oral Leukoplakia and Oral Squamous Cell Carcinoma.
    G D; Nandan SRK; Kulkarni PG
    Asian Pac J Cancer Prev; 2019 Jul; 20(7):2087-2093. PubMed ID: 31350970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salivary and Serum Interleukin-6: A Credible Marker for Predicting Oral Leukoplakia and Oral Squamous Cell Carcinoma by Enzyme-Linked Immunosorbent Assay (ELISA).
    Oshin M; Kulkarni PG; D SPR; Deepthi G; S KS; S JK
    Cureus; 2024 Apr; 16(4):e59113. PubMed ID: 38803729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimation of salivary matrix metalloproteinases- 12 (MMP- 12) levels among patients presenting with oral submucous fibrosis and oral squamous cell carcinoma.
    Saleem Z; Shaikh AH; Zaman U; Ahmed S; Majeed MM; Kazmi A; Farooqui WA
    BMC Oral Health; 2021 Apr; 21(1):205. PubMed ID: 33892690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A study of salivary lactate dehydrogenase isoenzyme levels in patients with oral leukoplakia and squamous cell carcinoma by gel electrophoresis method.
    Joshi PS; Golgire S
    J Oral Maxillofac Pathol; 2014 Sep; 18(Suppl 1):S39-44. PubMed ID: 25364177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An immunohistochemical evaluation of podoplanin expression in oral leukoplakia and oral squamous cell carcinoma to explore its potential to be used as a predictor for malignant transformation.
    Aiswarya A; Suresh R; Janardhanan M; Savithri V; Aravind T; Mathew L
    J Oral Maxillofac Pathol; 2019; 23(1):159. PubMed ID: 31110440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salivary MMP-9 as a Biomarker for the Diagnosis of Oral Potentially Malignant Disorders and Oral Squamous Cell Carcinoma.
    Smriti K; Ray M; Chatterjee T; Shenoy RP; Gadicherla S; Pentapati KC; Rustaqi N
    Asian Pac J Cancer Prev; 2020 Jan; 21(1):233-238. PubMed ID: 31983189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Proinflammatory, NF-kappaB Dependent Cytokines: IL-1α, IL-6, IL-8, and TNF-α in Tissue Specimens and Saliva of Patients with Oral Squamous Cell Carcinoma and Oral Potentially Malignant Disorders.
    Babiuch K; Kuśnierz-Cabala B; Kęsek B; Okoń K; Darczuk D; Chomyszyn-Gajewska M
    J Clin Med; 2020 Mar; 9(3):. PubMed ID: 32245251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased VEGFR2 and MMP9 protein levels are associated with epithelial dysplasia grading.
    de Carvalho Fraga CA; Farias LC; de Oliveira MV; Domingos PL; Pereira CS; Silva TF; Roy A; Gomez RS; de Paula AM; Guimarães AL
    Pathol Res Pract; 2014 Dec; 210(12):959-64. PubMed ID: 25441661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computer-Assisted Morphometric Comparative Analysis of Argyrophilic Nucleolar Organizer Regions (AgNORs) in Leukoplakia With Dysplasia and Oral Squamous Cell Carcinoma.
    Nararyanan RC; Sebastian BT; Sulaikha SH; Augustine C; Thomas T; Sudhakaran A
    Cureus; 2024 Feb; 16(2):e54471. PubMed ID: 38510852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Salivary Interleukin-6 in Patients with Oral Squamous Cell Carcinoma, Oral Potentially Malignant Disorders, Chronic Periodontitis and in Healthy Controls - A Cross-Sectional Comparative Study.
    Rani NAJ; Vardhan BGH; Srinivasan S; Gopal SK
    Ann Maxillofac Surg; 2023; 13(1):70-75. PubMed ID: 37711518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preliminary Study of the Cancer Stem Cells' Biomarker CD147 in Leukoplakia: Dysplasia and Squamous Cell Carcinoma of Oral Epithelial Origin.
    Zisis V; Andreadis D; Anastasiadou P; Vahtsevanos K; Akrivou M; Vizirianakis IS; Poulopoulos A
    Cureus; 2023 May; 15(5):e38807. PubMed ID: 37303447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of salivary levels of ErbB2 in oral squamous cell carcinoma.
    Jayarajkumar S; Ramamoorthi R; Muniapillai S; Gopalakrishnan S; Jayaseelan VP
    J Oral Maxillofac Pathol; 2023; 27(4):777. PubMed ID: 38304523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A study to estimate the serum IgA and salivary IgA levels in patients with oral leukoplakia and oral squamous cell carcinoma.
    Yadav P; Shetty V; Dave A; Chandolia B; Mathur A; Saluja P
    J Oral Maxillofac Pathol; 2023; 27(2):275-281. PubMed ID: 37854900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship of the XRCC1 rs25487 polymorphism with demographic, behavioral, clinical, and histological parameters in oral potentially malignant disorders and oral squamous cell carcinoma in a Colombian population.
    Hernández-Arenas YY; Támara-De Ávila JJ; Isaza-Guzmán DM; González-Pérez LV; Tobón-Arroyave SI
    J Oral Biosci; 2021 Jun; 63(2):217-223. PubMed ID: 33647453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salivary MMP-9 in the detection of oral squamous cell carcinoma.
    Peisker A; Raschke GF; Fahmy MD; Guentsch A; Roshanghias K; Hennings J; Schultze-Mosgau S
    Med Oral Patol Oral Cir Bucal; 2017 May; 22(3):e270-275. PubMed ID: 28160595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. E-cadherin Expression in Premalignant Lesions, Premalignant Conditions, Oral Squamous Cell Carcinoma, and Normal Mucosa: An Immunohistochemical Study.
    Kalaimani G; Rao UDK; Joshua E; Ranganathan K
    Cureus; 2023 Aug; 15(8):e44266. PubMed ID: 37772225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Cytotoxic T Lymphocytes and Natural Killer Cell Distribution in Oral Squamous Cell Carcinoma and Oral Epithelial Dysplasia: An Immunohistochemical Study.
    John S; Joseph AP; Raghavan Pillai VB; Ramani P; P J; Ramalingam K
    Cureus; 2024 Mar; 16(3):e56323. PubMed ID: 38628992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epithelial and fibroblast SPARC expression patterns in oral leukoplakia and oral squamous cell carcinoma.
    Poomsawat S; Kosanwat T; Meesakul O; Sanguansin S
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2022 Aug; 134(2):e44-e50. PubMed ID: 35165061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.